The post-endophthalmitis vitrectomy study era [3]

Archives of Ophthalmology

Volumn 120, Issue 2, 2002, Pages 233-234

  Durand, Marlene L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFTAZIDIME; VANCOMYCIN;

BACTERIAL VIRULENCE; BLOOD EYE BARRIER; CATARACT EXTRACTION; ENDOPHTHALMITIS; ENTEROCOCCUS; HUMAN; LETTER; MEDICAL DECISION MAKING; MEDICAL RESEARCH; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT PLANNING; VISUAL ACUITY; VITRECTOMY;

ANTI-INFECTIVE AGENTS; CATARACT EXTRACTION; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; HUMANS; POSTOPERATIVE COMPLICATIONS; VIRULENCE; VITRECTOMY;

EID: 0036131193     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Management of endophthalmitis in the post-Endophthalmitis Vitrectomy Study era
2. Microbiologic factors and visual outcome in the Endophthalmitis Vitrectomy study
3. Aminoglycoside levels in the rabbit vitreous cavity after intravenous administration
4. Additional procedures after the initial vitrectomy or tap-biopsy in the Endophthalmitis Vitrectomy study
5. Vitrectomy for infectious endophthalmitis
6. The Endophthalmitis Vitrectomy Study: Relationship between clinical presentation and microbiologic spectrum